{
    "2021-04-02": [
        [
            {
                "time": "",
                "original_text": "国信证券----医药生物行业2021年4月投资策略：调整后更均衡，优选内生成长【行业研究】",
                "features": {
                    "keywords": [
                        "国信证券",
                        "医药生物",
                        "投资策略",
                        "调整",
                        "内生成长"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "社保QFII持股路径曝光，化工电子板块各有所爱",
                "features": {
                    "keywords": [
                        "社保",
                        "QFII",
                        "持股路径",
                        "化工",
                        "电子"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "化工",
                        "电子"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}